|
1
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman SL and Bansal MB: Reversal of
hepatic fibrosis e fact or fantasy? Hepatology 43(2 Suppl 1).
S82–S88. 2006. View Article : Google Scholar
|
|
3
|
Parola M and Robino G: Oxidative
stress-related molecules and liver fibrosis. J Hepatol. 35:297–306.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balta C, Herman H, Boldura OM, Gasca I,
Rosu M, Ardelean A and Hermenean A: Chrysin attenuates liver
fibrosis and hepatic stellate cell activation through TGF-b/Smad
signaling pathway. Chem Biol Interact. 240:94–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williams E and Iredale J: Hepatic
regeneration and TGF-beta: Growing to a prosperous perfection. Gut.
46:593–594. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng Y, Yang H, Wang N, Ouyang Y, Yi Y,
Liao L, Shen H, Hu G, Wang Z and Tao L: Fluorofenidone attenuates
hepatic fibrosis by suppressing the proliferation and activation of
hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol.
306:253–263. 2014. View Article : Google Scholar
|
|
8
|
Peng Y, Yang H, Zhu T, Zhao M, Deng Y, Liu
B, Shen H, Hu G, Wang Z and Tao L: The antihepatic fibrotic effects
of fluorofenidone via MAPK signalling pathways. Eur J Clin Invest.
43:358–368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang Y, Zhang F, Huang L, Yuan Q, Qin J,
Li B, Wang N, Xie Y, Wang L, Wang W, et al: The protective
mechanism of fluorofenidone in renal interstitial inflammation and
fibrosis. Am J Med Sci. 350:195–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song C, He L, Zhang J, Ma H, Yuan X, Hu G,
Tao L, Zhang J and Meng J: Fluorofenidone attenuates pulmonary
inflammation and fibrosis via inhibiting the activation of NALP3
inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. J Cell Mol Med.
20:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LX, Yang K, Sun M, Chen Q, Wang ZH,
Hu GY and Tao LJ: Fluorofenidone inhibits transforming growth
factor-beta1-induced cardiac myofibroblast differentiation.
Pharmazie. 67:452–456. 2012.PubMed/NCBI
|
|
12
|
Xu L, Hui AY, Albanis E, Arthur MJ,
O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL and Eng FJ: Human
hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis
of hepatic fibrosis. Gut. 54:142–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paronetto F and Popper H: Chronic liver
injury induced by immunologic reactions Cirrhosis following
immunization with heterologous sera. Am J Pathol. 49:1087–1101.
1966.PubMed/NCBI
|
|
14
|
Benedetti A, Di Sario A, Casini A, Ridolfi
F, Bendia E, Pigini P, Tonnini C, D'Ambrosio L, Feliciangeli G,
Macarri G and Svegliati-Baroni G: Inhibition of the NA(+)/H(+)
exchanger reduces rat hepatic stellate cell activity and liver
fibrosis: An in vitro and in vivo study. Gastroenterology.
120:545–556. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Sario A, Bendia E, Taffetani S,
Marzioni M, Candelaresi C, Pigini P, Schindler U, Kleemann HW,
Trozzi L, Macarri G and Benedetti A: Selective Na+/H+ exchange
inhibition by cariporide reduces liver fibrosis in the rat.
Hepatology. 37:256–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chevallier M, Guerret S, Chossegros P,
Gerard F and Grimaud JA: A histological semi-quantitative scoring
system for evaluation of hepatic fibrosis in needle liver biopsy
specimens: Comparison with morphometric studies. Hepatology.
20:349–355. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen
L, Chen J, Zeng L, Fan J, Li X, et al: Proteome analysis and tissue
microarray for profiling protein markers associated with lymph node
metastasis in colorectal cancer. J Proteome Res. 6:2495–2501. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Broekema M, Harmsen MC, van Luyn MJ,
Koerts JA, Petersen AH, van Kooten TG, van Goor H, Navis G and Popa
ER: Bone marrow-derived myofibroblasts contribute to the renal
interstitial myofibroblast population and produce procollagen I
after ischemia/reperfusion in rats. J Am Soc Nephrol. 18:165–175.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Winer J, Jung CK, Shackel I and Williams
PM: Development and validation of real-time quantitative reverse
transcriptase-polymerase chain reaction for monitoring gene
expression in cardiacmyocytes in vitro. Anal Biochem. 270:41–49.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsui HT, Wea LL, Zi HC, Lee YJ, Shie MS,
Lee KF, Shen CH and Kuo HC: Moniliformediquinone as a potential
therapeutic agent, inactivation of hepatic stellate cell and
inhibition of liver fibrosis in vivo. J Transl Med. 14:2632016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferrell LD and Kakar S: Liver Pathology.
Demos Medical. (New York, NY). 2011.
|
|
22
|
Saber S, Goda R, El-Tanbouly GS and Ezzat
D: Lisinopril inhibits nuclear transcription factor kappa B and
augments sensitivity to silymarin in experimental liver fibrosis.
Int Immunopharmacol. 64:340–349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Domitrović R and Jakovac H: Effects of
standardized bilberry fruit extract (Mirtoselect®) on
resolution of CCl4-induced liver fibrosis in mice. Food Chem
Toxicol. 49:848–854. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY,
Shyu JC, Hsieh YS, Tsai CC and Liu YC: Effects of silymarin on the
resolution of liver fibrosis induced by carbon tetrachloride in
rats. J Viral Hepat. 15:508–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhan L, Huang C, Meng XM, Song Y, Wu XQ,
Yang Y and Li J: Hypoxia-inducible factor-1alpha in hepatic
fibrosis: A promising therapeutic target. Biochimie. 108:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q,
Deng X, Wang J, Zhang J and Guo C: Antifibrotic effects of luteolin
on hepatic stellate cells and liver fibrosis by targeting
AKT/mTOR/p70S6K and TGFb/Smad signalling pathways. Liver Int.
35:1222–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park JH, Yoon J, Lee KY and Park B:
Effects of geniposide on hepatocytes undergoing
epitheliale-mesenchymal transition in hepatic fibrosis by targeting
TGFb/Smad and ERK-MAPK signaling pathways. Biochimie. 113:26–34.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang JH, Kim SC, Kim KM, Jang CH, Cho SS,
Kim SJ, Ku SK, Cho IJ and Ki SH: Isorhamnetin attenuates liver
fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative
stress. Eur J Pharmacol. 783:92–102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Borkham-Kamphorst E, Herrmann J, Stoll D,
Treptau J, Gressner AM and Weiskirchen R: Dominant-negative soluble
PDGF-beta receptor inhibits hepatic stellate cell activation and
attenuates liver fibrosis. Lab Invest. 84:766–777. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tahashi Y, Matsuzaki K, Date M, Yoshida K,
Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y and Inoue
K: Differential regulation of TGF-beta signal in hepatic stellate
cells between acute and chronic rat liver injury. Hepatology.
35:49–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marra F, Galastri S, Aleffi S and Pinzani
M: Stellate cells. Dufour JF and Clavien PA: Signaling pathways in
liver diseases. (Springer-Verlag, Berlin, Heidelberg).
2010.41–68
|
|
34
|
Friedman SL: Mechanisms of disease:
Mechanismsofhepatic fibrosis and therapeutic implications. Nat Clin
Pract Gastroenterol Hepatol. 1:98–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gauldie J, Bonniaud P, Sime P, Ask K and
Kolb M: TGF-beta, Smad3 and the process of progressive fibrosis.
Biochem Soc Trans. 35:661–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Parsons CJ, Takashima M and Rippe RA:
Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol
Hepatol. 22 (Suppl 1):S79–S84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feng XH and Derynck R: Specificity and
versatility in tgf-beta signaling through smads. Annu Rev Cell Dev
Biol. 21:659–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho HJ, Baek KE, Saika S, Jeong MJ and Yoo
J: Snail is required for transforming growth factor-beta-induced
epithelial-mesenchymal transition by activating PI3 kinase/Akt
signal pathway. Biochem Biophys Res Commun. 353:337–343. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Burch ML, Zheng W and Little PJ: Smad
linker region phosphorylation in the regulation of extracellular
matrix synthesis. Cell Mol Life Sci. 68:97–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matsuura I, Wang G, He D and Liu F:
Identification and characterization of ERK MAP kinase
phosphorylation sites in Smad3. Biochemistry. 44:12546–12553. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim YS, Kim J, Kim KM, Jung DH, Choi S,
Kim CS and Kim JS: Myricetin inhibits advanced glycation end
product (AGE)-induced migration of retinal pericytes through
phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in
vivo. Biochem Pharmacol. 93:496–505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lechuga CG, Hernández-Nazara ZH, Domínguez
Rosales JA, Morris ER, Rincón AR, Rivas-Estilla AM, Esteban-Gamboa
A and Rojkind M: TGF-beta1 modulates matrix metalloproteinase-13
expression in hepatic stellate cells by complex mechanisms
involving p38MAPK, PI3-kinase, AKT, and p70S6k. Am J Physiol
Gastrointest Liver Physiol. 287:G974–G987. 2004. View Article : Google Scholar : PubMed/NCBI
|
